BSGCBigString Corporation
The schedule
- Thu15Oct
Given the severe lapse in consistent filings, BSGC faces acute delisting or caveat emptor risk. Surviving the review without suspension could re-rate the stock to $0.00015, but the adverse path targets $0.00002.
- Fri20Nov
Following potential regulatory hurdles, the Q3 2026 Earnings Release poses another major risk event. A purely speculative beat could see a brief jump to $0.00006, but ongoing cash burn makes the $0.00001 fallback highly likely.
- Fri27Nov
- Mon15Feb
A late-winter window for management to announce a reverse merger or strategic alternative. A definitive deal could push the shell value to $0.00005, whereas prolonged silence guarantees a fade to $0.000005.
- Fri26Feb
- Wed31Mar
The deadline for full-year FY26 results. Filing actual financials could provide enough clarity to rally the stock to $0.00002, but failure to file drops the valuation to $0.000001.
- Fri28May
- Fri27Aug
Past
- Fri28Aug
With BSGC operating as a highly distressed micro-cap, the expected Q2 2026 Earnings Release will likely confirm severe fundamental deterioration. Favorable resolution implies a spike to $0.0002 on purely speculative volume, while the adverse base case implies dropping to $0.00005 due to continued operational failure.